Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fleischhauer

Showing results (441-450 of 529) with videos related to

Pageof 53
Sort By:
Bone Marrow Transplantation|November 14, 2017
Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinomaR Crocchiolo, O Ringden, J-O Bay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2023
Impact of the HLA Immunopeptidome on Survival of Leukemia Patients After Unrelated Donor TransplantationPietro Crivello, Esteban Arrieta-Bolaños, Meilun He, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 18, 2016
MHC Class I Chain-Related Gene A (MICA) Donor-Recipient Mismatches and MICA-129 Polymorphism in Unrelated Donor Hematopoietic Cell Transplantations Has No Impact on Outcomes in Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome: A Center for International Blood and Marrow Transplant Research StudyMedhat Askar, Ronald Sobecks, Tao Wang, et al.
American Journal of Hematology|January 13, 2021
Cytomegalovirus kinetics after hematopoietic cell transplantation reveal peak titers with differential impact on mortality, relapse and immune reconstitutionSaskia Leserer, Evren Bayraktar, Mirko Trilling, et al.
The Journal of Investigative Dermatology|April 2, 2021
Melanoma Differentiation Trajectories Determine Sensitivity toward Pre-Existing CD8<sup>+</sup> Tumor-Infiltrating LymphocytesFranziska Noelle Harbers, Beatrice Thier, Simone Stupia, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 21, 2017
Impact of HLA Alleles on Outcomes of Allogeneic Transplantation for B Cell Non-Hodgkin Lymphomas: A Center for International Blood and Marrow Transplant Research AnalysisBasem M William, Tao Wang, Michael D Haagenson, et al.
Bone Marrow Transplantation|August 12, 2014
BAT2 and BAT3 polymorphisms as novel genetic risk factors for rejection after HLA-related SCTIgnazio Stefano Piras, Andrea Angius, Marco Andreani, et al.
Transplantation and Cellular Therapy|March 9, 2025
Outcome of Patients With IDH-Mutated AML Following Allogeneic Stem Cell Transplantation-A Retrospective Analysis on Behalf of the German Registry for Hematopoietic Stem Cell Transplantation and Cell Therapy, DRSTThomas Schroeder, Sarah Flossdorf, Claudia Schuh, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 10, 2019
Optimizing anti-T-lymphocyte globulin dosing to improve long-term outcome after unrelated hematopoietic cell transplantation for hematologic malignanciesAmin T Turki, Vesna Klisanin, Evren Bayraktar, et al.
HLA|May 21, 2026
Escape From Synthetic T Cell Activator Tebentafusp by Genomic HLA Loss: A Case ReportHalime Kalkavan, Andreas Heinold, Siyang Liu, et al.
Pageof 53

Showing results (441-450 of 529) with videos related to

Sort By:
Pageof 53
Bone Marrow Transplantation|November 14, 2017
Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinomaR Crocchiolo, O Ringden, J-O Bay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2023
Impact of the HLA Immunopeptidome on Survival of Leukemia Patients After Unrelated Donor TransplantationPietro Crivello, Esteban Arrieta-Bolaños, Meilun He, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 18, 2016
MHC Class I Chain-Related Gene A (MICA) Donor-Recipient Mismatches and MICA-129 Polymorphism in Unrelated Donor Hematopoietic Cell Transplantations Has No Impact on Outcomes in Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome: A Center for International Blood and Marrow Transplant Research StudyMedhat Askar, Ronald Sobecks, Tao Wang, et al.
American Journal of Hematology|January 13, 2021
Cytomegalovirus kinetics after hematopoietic cell transplantation reveal peak titers with differential impact on mortality, relapse and immune reconstitutionSaskia Leserer, Evren Bayraktar, Mirko Trilling, et al.
The Journal of Investigative Dermatology|April 2, 2021
Melanoma Differentiation Trajectories Determine Sensitivity toward Pre-Existing CD8<sup>+</sup> Tumor-Infiltrating LymphocytesFranziska Noelle Harbers, Beatrice Thier, Simone Stupia, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 21, 2017
Impact of HLA Alleles on Outcomes of Allogeneic Transplantation for B Cell Non-Hodgkin Lymphomas: A Center for International Blood and Marrow Transplant Research AnalysisBasem M William, Tao Wang, Michael D Haagenson, et al.
Bone Marrow Transplantation|August 12, 2014
BAT2 and BAT3 polymorphisms as novel genetic risk factors for rejection after HLA-related SCTIgnazio Stefano Piras, Andrea Angius, Marco Andreani, et al.
Transplantation and Cellular Therapy|March 9, 2025
Outcome of Patients With IDH-Mutated AML Following Allogeneic Stem Cell Transplantation-A Retrospective Analysis on Behalf of the German Registry for Hematopoietic Stem Cell Transplantation and Cell Therapy, DRSTThomas Schroeder, Sarah Flossdorf, Claudia Schuh, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 10, 2019
Optimizing anti-T-lymphocyte globulin dosing to improve long-term outcome after unrelated hematopoietic cell transplantation for hematologic malignanciesAmin T Turki, Vesna Klisanin, Evren Bayraktar, et al.
HLA|May 21, 2026
Escape From Synthetic T Cell Activator Tebentafusp by Genomic HLA Loss: A Case ReportHalime Kalkavan, Andreas Heinold, Siyang Liu, et al.
Pageof 53